These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 31479642)

  • 1. Gender Differences in Outcomes After Implantation of Left Ventricular Assist Devices.
    Ahmed A; Adegbala O; Akintoye E; Inampudi C; Ajam M; Yassin AS; Olawusi E; Shokr M; Alvarez P; Briasoulis A
    Ann Thorac Surg; 2020 Mar; 109(3):780-786. PubMed ID: 31479642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-Based Differences in Left Ventricular Assist Device Utilization: Insights From the Nationwide Inpatient Sample 2004 to 2016.
    Joshi AA; Lerman JB; Sajja AP; Dahiya G; Gokhale AV; Dey AK; Kyvernitakis A; Halbreiner MS; Bailey S; Alpert CM; Poornima IG; Murali S; Benza RL; Kanwar M; Raina A
    Circ Heart Fail; 2019 Sep; 12(9):e006082. PubMed ID: 31514517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National Trends in Utilization, Mortality, Complications, and Cost of Care After Left Ventricular Assist Device Implantation From 2005 to 2011.
    Shah N; Agarwal V; Patel N; Deshmukh A; Chothani A; Garg J; Badheka A; Martinez M; Islam N; Freudenberger R
    Ann Thorac Surg; 2016 Apr; 101(4):1477-84. PubMed ID: 26588867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Hospital Ownership on Outcomes After Left Ventricular Assist Device Implantation in the United States.
    Briasoulis A; Inampudi C; Akintoye E; Adegbala O; Bhama J; Alvarez P
    Ann Thorac Surg; 2019 Feb; 107(2):527-532. PubMed ID: 30316859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in Utilization, Mortality, Major Complications, and Cost After Left Ventricular Assist Device Implantation in the United States (2009 to 2014).
    Briasoulis A; Inampudi C; Akintoye E; Adegbala O; Alvarez P; Bhama J
    Am J Cardiol; 2018 May; 121(10):1214-1218. PubMed ID: 29525059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular assist device outcomes based on flow configuration and pre-operative left ventricular dimension: An Interagency Registry for Mechanically Assisted Circulatory Support Analysis.
    Shah P; Birk S; Maltais S; Stulak J; Elmi A; Pagani FD; Cowger JA
    J Heart Lung Transplant; 2017 Jun; 36(6):640-649. PubMed ID: 28087105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Impact of Diabetes Mellitus on Short-Term Outcomes andIn-Hospital Mortality of Cardiac Mechanical Support with Left Ventricular Assist Device (LVAD): A Retrospective Study from a National Database.
    Yassin AS; Subahi A; Adegbala O; Abubakar H; Akintoye E; Ahmed A; Ismail A; Elhag A; Kambal A; Alade A; Shokr M; Weinberger J; Levine D; Afonso L
    Cardiovasc Revasc Med; 2019 Oct; 20(10):883-886. PubMed ID: 30578171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-institutional outcome analysis of patients undergoing left ventricular assist device implantation stratified by sex and race.
    Meeteren JV; Maltais S; Dunlay SM; Haglund NA; Beth Davis M; Cowger J; Shah P; Aaronson KD; Pagani FD; Stulak JM
    J Heart Lung Transplant; 2017 Jan; 36(1):64-70. PubMed ID: 27793517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Postoperative Liver Dysfunction on Survival After Left Ventricular Assist Device Implantation.
    Majumder K; Spratt JR; Holley CT; Roy SS; Cogswell RJ; Liao K; John R
    Ann Thorac Surg; 2017 Nov; 104(5):1556-1562. PubMed ID: 28760474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echocardiographic variables after left ventricular assist device implantation associated with adverse outcome.
    Topilsky Y; Hasin T; Oh JK; Borgeson DD; Boilson BA; Schirger JA; Clavell AL; Frantz RP; Tsutsui R; Liu M; Maltais S; Kushwaha SS; Pereira NL; Park SJ
    Circ Cardiovasc Imaging; 2011 Nov; 4(6):648-61. PubMed ID: 21940507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, predictors, and clinical impact of electrical storm in patients with left ventricular assist devices: New insights from the ASSIST-ICD study.
    Martins RP; Leclercq C; Bourenane H; Auffret V; Boulé S; Loobuyck V; Dambrin C; Mondoly P; Sacher F; Bordachar P; Kindo M; Cardi T; Gaudard P; Rouvière P; Michel M; Gourraud JB; Defaye P; Chavanon O; Kerneis C; Ghodhbane W; Pelcé E; Gariboldi V; Pozzi M; Grinberg D; Litzler PY; Anselme F; Babatasi G; Belin A; Garnier F; Bielefeld M; Hamon D; Lellouche N; Pierre B; Bourguignon T; Eschallier R; D'Ostrevy N; Bories MC; Jouan J; Vanhuyse F; Sadoul N; Flécher E; Galand V
    Heart Rhythm; 2019 Oct; 16(10):1506-1512. PubMed ID: 31255846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcomes After Left Ventricular Assist Device Implantation in Older Adults: An INTERMACS Analysis.
    Caraballo C; DeFilippis EM; Nakagawa S; Ravindra NG; Miller PE; Mezzacappa C; McCullough M; Gruen J; Levin A; Reinhardt S; Mullan C; Ali A; Maurer MS; Desai NR; Ahmad T; Topkara VK
    JACC Heart Fail; 2019 Dec; 7(12):1069-1078. PubMed ID: 31779930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity as a Risk Factor for Consideration for Left Ventricular Assist Devices.
    Mohamedali B; Yost G; Bhat G
    J Card Fail; 2015 Oct; 21(10):800-5. PubMed ID: 26093334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The aspartate transaminase/alanine transaminase (DeRitis) ratio predicts mid-term mortality and renal and respiratory dysfunction after left ventricular assist device implantation.
    Pilarczyk K; Carstens H; Heckmann J; Canbay A; Koch A; Pizanis N; Jakob H; Kamler M
    Eur J Cardiothorac Surg; 2017 Oct; 52(4):781-788. PubMed ID: 29156019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive Care Unit Readmission After Left Ventricular Assist Device Implantation: Causes, Associated Factors, and Association With Patient Mortality.
    Hui J; Mauermann WJ; Stulak JM; Hanson AC; Maltais S; Barbara DW
    Anesth Analg; 2019 Jun; 128(6):1168-1174. PubMed ID: 31094784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends, Outcomes, and Readmissions Among Left Ventricular Assist Device Recipients with Acute Kidney Injury Requiring Hemodialysis.
    Adegbala O; Olakanmi O; Akintoye E; Inampudi C; Pahuja M; Alvarez P; Briasoulis A
    ASAIO J; 2020 May; 66(5):507-512. PubMed ID: 31192850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
    Topkara VK; Kondareddy S; Malik F; Wang IW; Mann DL; Ewald GA; Moazami N
    Ann Thorac Surg; 2010 Oct; 90(4):1270-7. PubMed ID: 20868826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.